ARCHIVES

Von Eschenbach a “misguided choice” for FDA, House members write to HHS Secretary Leavitt. Conflicts inadequately addressed, they said.

This article is from The Cancer Letter archive.

Vol. 31 No. 37 | October 14, 2005

Download PDF Visit The Full Archive

Related Articles

Report calls for stronger peer review, prioritization for cancer clinical trials.

June 10, 2005

Senior Biomedical Service Proposed To Increase Pay

April 1, 1988

Hammer Signs $2.5 Mil. Check To NCI Fro Stop Cancer Campaign

February 2, 1990

Senate Approves Appropriations Bill; GRH Threatens It

October 23, 1987

Giaccone Joins Georgetown Lombardi Center

February 22, 2013

NCI Advisory Group, Other Cancer Meetings

November 26, 1976